BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 35793392)

  • 1. In vivo genome-wide CRISPR screening in murine acute myeloid leukemia uncovers microenvironmental dependencies.
    Mercier FE; Shi J; Sykes DB; Oki T; Jankovic M; Man CH; Kfoury YS; Miller E; He S; Zhu A; Vasic R; Doench J; Orthwein A; Michor F; Scadden DT
    Blood Adv; 2022 Sep; 6(17):5072-5084. PubMed ID: 35793392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Multiplex CRISPR-Screen Identifies PLA2G4A as Prognostic Marker and Druggable Target for HOXA9 and MEIS1 Dependent AML.
    Hassan JJ; Lieske A; Dörpmund N; Klatt D; Hoffmann D; Kleppa MJ; Kustikova OS; Stahlhut M; Schwarzer A; Schambach A; Maetzig T
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502319
    [No Abstract]   [Full Text] [Related]  

  • 3. MicroRNA-708 is a novel regulator of the Hoxa9 program in myeloid cells.
    Schneider E; Pochert N; Ruess C; MacPhee L; Escano L; Miller C; Krowiorz K; Delsing Malmberg E; Heravi-Moussavi A; Lorzadeh A; Ashouri A; Grasedieck S; Sperb N; Kumar Kopparapu P; Iben S; Staffas A; Xiang P; Rösler R; Kanduri M; Larsson E; Fogelstrand L; Döhner H; Döhner K; Wiese S; Hirst M; Keith Humphries R; Palmqvist L; Kuchenbauer F; Rouhi A
    Leukemia; 2020 May; 34(5):1253-1265. PubMed ID: 31768018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Exploration of novel therapeutic targets in acute myeloid leukemia via genome-wide CRISPR screening].
    Yamauchi T
    Rinsho Ketsueki; 2019; 60(7):810-817. PubMed ID: 31391371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An in vivo genome-wide CRISPR screen identifies the RNA-binding protein Staufen2 as a key regulator of myeloid leukemia.
    Bajaj J; Hamilton M; Shima Y; Chambers K; Spinler K; Van Nostrand EL; Yee BA; Blue SM; Chen M; Rizzeri D; Chuah C; Oehler VG; Broome HE; Sasik R; Scott-Browne J; Rao A; Yeo GW; Reya T
    Nat Cancer; 2020 Apr; 1(4):410-422. PubMed ID: 34109316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The endothelin receptor type A is a downstream target of Hoxa9 and Meis1 in acute myeloid leukemia.
    Arabanian LS; Johansson P; Staffas A; Nilsson T; Rouhi A; Fogelstrand L; Palmqvist L
    Leuk Res; 2018 Dec; 75():61-68. PubMed ID: 30384975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of Flt3 is a passive event in Hoxa9/Meis1-induced acute myeloid leukemia in mice.
    Staffas A; Arabanian LS; Wei SY; Jansson A; Ståhlman S; Johansson P; Fogelstrand L; Cammenga J; Kuchenbauer F; Palmqvist L
    Oncogene; 2017 Mar; 36(11):1516-1524. PubMed ID: 27617578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A CRISPR Dropout Screen Identifies Genetic Vulnerabilities and Therapeutic Targets in Acute Myeloid Leukemia.
    Tzelepis K; Koike-Yusa H; De Braekeleer E; Li Y; Metzakopian E; Dovey OM; Mupo A; Grinkevich V; Li M; Mazan M; Gozdecka M; Ohnishi S; Cooper J; Patel M; McKerrell T; Chen B; Domingues AF; Gallipoli P; Teichmann S; Ponstingl H; McDermott U; Saez-Rodriguez J; Huntly BJP; Iorio F; Pina C; Vassiliou GS; Yusa K
    Cell Rep; 2016 Oct; 17(4):1193-1205. PubMed ID: 27760321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome wide CRISPR screening reveals a role for sialylation in the tumorigenesis and chemoresistance of acute myeloid leukemia cells.
    Lee DH; Kang SH; Choi DS; Ko M; Choi E; Ahn H; Min H; Oh SJ; Lee MS; Park Y; Jin HS
    Cancer Lett; 2021 Jul; 510():37-47. PubMed ID: 33872695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The EMT regulator ZEB2 is a novel dependency of human and murine acute myeloid leukemia.
    Li H; Mar BG; Zhang H; Puram RV; Vazquez F; Weir BA; Hahn WC; Ebert B; Pellman D
    Blood; 2017 Jan; 129(4):497-508. PubMed ID: 27756750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic Target Discovery Using High-Throughput Genetic Screens in Acute Myeloid Leukemia.
    Liu Q; Garcia M; Wang S; Chen CW
    Cells; 2020 Aug; 9(8):. PubMed ID: 32806592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surface antigen-guided CRISPR screens identify regulators of myeloid leukemia differentiation.
    Wang E; Zhou H; Nadorp B; Cayanan G; Chen X; Yeaton AH; Nomikou S; Witkowski MT; Narang S; Kloetgen A; Thandapani P; Ravn-Boess N; Tsirigos A; Aifantis I
    Cell Stem Cell; 2021 Apr; 28(4):718-731.e6. PubMed ID: 33450187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional control of leukemogenesis by the chromatin reader SGF29.
    Barbosa K; Deshpande A; Perales M; Xiang P; Murad R; Pramod AB; Minkina A; Robertson N; Schischlik F; Lei X; Sun Y; Brown A; Amend D; Jeremias I; Doench JG; Humphries RK; Ruppin E; Shendure J; Mali P; Adams PD; Deshpande AJ
    Blood; 2024 Feb; 143(8):697-712. PubMed ID: 38048593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meis2 as a critical player in MN1-induced leukemia.
    Lai CK; Norddahl GL; Maetzig T; Rosten P; Lohr T; Sanchez Milde L; von Krosigk N; Docking TR; Heuser M; Karsan A; Humphries RK
    Blood Cancer J; 2017 Sep; 7(9):e613. PubMed ID: 28960191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HOXBLINC long non-coding RNA activation promotes leukemogenesis in NPM1-mutant acute myeloid leukemia.
    Zhu G; Luo H; Feng Y; Guryanova OA; Xu J; Chen S; Lai Q; Sharma A; Xu B; Zhao Z; Feng R; Ni H; Claxton D; Guo Y; Mesa RA; Qiu Y; Yang FC; Li W; Nimer SD; Huang S; Xu M
    Nat Commun; 2021 Mar; 12(1):1956. PubMed ID: 33782403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PBX3 and MEIS1 Cooperate in Hematopoietic Cells to Drive Acute Myeloid Leukemias Characterized by a Core Transcriptome of the MLL-Rearranged Disease.
    Li Z; Chen P; Su R; Hu C; Li Y; Elkahloun AG; Zuo Z; Gurbuxani S; Arnovitz S; Weng H; Wang Y; Li S; Huang H; Neilly MB; Wang GG; Jiang X; Liu PP; Jin J; Chen J
    Cancer Res; 2016 Feb; 76(3):619-29. PubMed ID: 26747896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endogenous Tumor Suppressor microRNA-193b: Therapeutic and Prognostic Value in Acute Myeloid Leukemia.
    Bhayadia R; Krowiorz K; Haetscher N; Jammal R; Emmrich S; Obulkasim A; Fiedler J; Schwarzer A; Rouhi A; Heuser M; Wingert S; Bothur S; Döhner K; Mätzig T; Ng M; Reinhardt D; Döhner H; Zwaan CM; van den Heuvel Eibrink M; Heckl D; Fornerod M; Thum T; Humphries RK; Rieger MA; Kuchenbauer F; Klusmann JH
    J Clin Oncol; 2018 Apr; 36(10):1007-1016. PubMed ID: 29432078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Historical Relationship Between Meis1 and Leukemia.
    Meriç N; Kocabaş F
    Adv Exp Med Biol; 2022; 1387():127-144. PubMed ID: 35304708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p27kip1 maintains a subset of leukemia stem cells in the quiescent state in murine MLL-leukemia.
    Zhang J; Seet CS; Sun C; Li J; You D; Volk A; Breslin P; Li X; Wei W; Qian Z; Zeleznik-Le NJ; Zhang Z; Zhang J
    Mol Oncol; 2013 Dec; 7(6):1069-82. PubMed ID: 23988911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene Essentiality Profiling Reveals Gene Networks and Synthetic Lethal Interactions with Oncogenic Ras.
    Wang T; Yu H; Hughes NW; Liu B; Kendirli A; Klein K; Chen WW; Lander ES; Sabatini DM
    Cell; 2017 Feb; 168(5):890-903.e15. PubMed ID: 28162770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.